Synthetic Genomics

California-based Synthetic Genomics Vaccines, a company formed by Maryland-based Synthetic Genomics and the J. Craig Venter Institute in 2010, is working with Switzerland-based Novartis on a three-year project to develop vaccines based on synthetic genome technology. Synthetic Genomics Vaccines will bring business acumen to the project, while building upon Venter Institute’s genomic sequencing and synthetic genomes work, reports say.

Products 1 to 2 of 2

Attenuated Virus Cultures for Vaccine Production
ON THE HORIZON
Medicine from USA, Switzerland by J. Craig Venter Institute, Novartis, Synthetic Genomics.
Humanized Pig Organs
ON THE HORIZON
Medicine from USA by Synthetic Genomics, Lung Biotechnology.